MA50358A - Sémaglutide en thérapie médicale - Google Patents

Sémaglutide en thérapie médicale

Info

Publication number
MA50358A
MA50358A MA050358A MA50358A MA50358A MA 50358 A MA50358 A MA 50358A MA 050358 A MA050358 A MA 050358A MA 50358 A MA50358 A MA 50358A MA 50358 A MA50358 A MA 50358A
Authority
MA
Morocco
Prior art keywords
semaglutide
medical therapy
therapy
medical
Prior art date
Application number
MA050358A
Other languages
English (en)
Inventor
Thomas Hansen
Maria Kabisch
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA50358A publication Critical patent/MA50358A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
MA050358A 2017-10-12 2018-10-10 Sémaglutide en thérapie médicale MA50358A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17196254 2017-10-12

Publications (1)

Publication Number Publication Date
MA50358A true MA50358A (fr) 2020-08-19

Family

ID=60083831

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050358A MA50358A (fr) 2017-10-12 2018-10-10 Sémaglutide en thérapie médicale

Country Status (16)

Country Link
US (1) US20200237876A1 (fr)
EP (1) EP3694538A1 (fr)
JP (1) JP7148605B2 (fr)
KR (1) KR20200069316A (fr)
CN (1) CN111212657A (fr)
AU (1) AU2018348929A1 (fr)
BR (1) BR112020006246A2 (fr)
CA (1) CA3078652A1 (fr)
CL (1) CL2020000812A1 (fr)
IL (1) IL273470A (fr)
MA (1) MA50358A (fr)
MX (1) MX2020003049A (fr)
PH (1) PH12020550185A1 (fr)
SG (1) SG11202002841PA (fr)
TW (1) TW201914611A (fr)
WO (1) WO2019072941A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220143037A (ko) * 2020-02-18 2022-10-24 노보 노르디스크 에이/에스 Glp-1 조성물 및 이의 용도
EP4313016A1 (fr) * 2021-03-29 2024-02-07 Sanford Health Procédés et compositions pour le traitement de troubles du stockage lysosomal
WO2023238017A1 (fr) * 2022-06-08 2023-12-14 Zydus Lifesciences Limited Injecteur en stylo unique à dose variable multidose réutilisable pour le traitement du diabète de type 2 et la gestion du poids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI362392B (en) 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
JP6034781B2 (ja) * 2010-05-05 2016-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 併用療法
CN104519902B (zh) * 2012-05-08 2017-10-27 诺和诺德股份有限公司 双酰化glp‑1衍生物
BR112014032938A2 (pt) * 2012-07-01 2017-08-01 Novo Nordisk As uso de peptídeos de glp-1 de longa ação
RU2671406C2 (ru) * 2013-05-02 2018-10-31 Ново Нордиск А/С Пероральная дозированная форма соединений глюкагоноподобного пептида-1

Also Published As

Publication number Publication date
TW201914611A (zh) 2019-04-16
RU2020114960A3 (fr) 2022-02-11
JP7148605B2 (ja) 2022-10-05
MX2020003049A (es) 2020-07-27
JP2020536854A (ja) 2020-12-17
SG11202002841PA (en) 2020-04-29
KR20200069316A (ko) 2020-06-16
AU2018348929A1 (en) 2020-05-07
RU2020114960A (ru) 2021-10-28
EP3694538A1 (fr) 2020-08-19
BR112020006246A2 (pt) 2021-03-30
IL273470A (en) 2020-05-31
CN111212657A (zh) 2020-05-29
WO2019072941A1 (fr) 2019-04-18
CA3078652A1 (fr) 2019-04-18
JP2022132414A (ja) 2022-09-08
US20200237876A1 (en) 2020-07-30
CL2020000812A1 (es) 2020-08-14
PH12020550185A1 (en) 2021-03-01

Similar Documents

Publication Publication Date Title
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
DK3191020T3 (da) Medicinsk/kirurgisk implantat
DK3590543T3 (da) Medicinsk forbinding
DK3142637T3 (da) Keratin treatment formulations and methods
DK3474802T3 (da) Medicinsk forbinding
DK3141199T3 (da) Medicinsk mikrorobot og mikrorobotsystem med samme
DK3474804T3 (da) Medicinsk forbinding
BR112017002074A2 (pt) vestuário e método de compressão médica terapêutica
IL250990A0 (en) Materials for human care
SG10202010420TA (en) Patient interface and aspects thereof
DK3373874T3 (da) Medicinsk forbinding
DK3393478T3 (da) Kombinationsterapi
GB201604213D0 (en) Drug combination and its use in therapy
DK3432970T3 (da) In vivo lægemiddelleveringsindretninger
DK3678714T3 (da) Vævsmanipuleret medicinsk indretning
DK3606926T3 (da) Heteroaromatiske forbindelser anvendelige i terapi
DK3408265T3 (da) Terapeutiske forbindelser
DK3474803T3 (da) Medicinsk forbinding
IL273470A (en) Semaglutide in medical treatment
ITUA20163417A1 (it) Fat and medical uses thereof
DK3302478T3 (da) Pac-1 kombinations behandling
DK3188599T3 (da) Medicinske behandlinger baseret på anamorelin
DK3325027T3 (da) Medicinsk implantat
DK3325478T3 (da) Ny terapeutisk forbindelse og anvendelse i terapi
DK3496106T3 (da) Medicinsk forbinding